World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
12173
World Ranking
3621
National Ranking
315

Eduard J. Sanders publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eduard J. Sanders sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 290 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eduard J. Sanders D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eduard J. Sanders sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eduard J. Sanders is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on the field of Medicine, with specialization in Infectious Diseases, Epidemiology, Virology, General Health Professions, and Microbiology.

The main topics covered in their work include:

  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • HIV Research and Treatment
  • Adolescent Sexual and Reproductive Health
  • Sex work and related issues
  • HIV/AIDS Impact and Responses
  • HIV-related health complications and treatments

Eduard J. Sanders has contributed extensively to several publication venues, with repeated publications in:

  • Harvard Dataverse
  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS ONE
  • Journal of the International AIDS Society
  • UNC Libraries

Recent notable papers include:

  • "African-led health research and capacity building- is it working?" (2020), published in BMC Public Health
  • "Integrating HIV and mental health interventions to address a global syndemic among men who have sex with men" (2022), published in The Lancet HIV
  • "PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men" (2020), published in EClinicalMedicine
  • "A Randomized Controlled Trial of the Shikamana Intervention to Promote Antiretroviral Therapy Adherence Among Gay, Bisexual, and Other Men Who Have Sex with Men in Kenya: Feasibility, Acceptability, Safety and Initial Effect Size" (2020), published in AIDS and Behavior
  • ""I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya" (2021), published in PLoS ONE

Frequent collaborators in their research include:

  • Susan M. Graham
  • Elise van der Elst
  • Elizabeth Wahome
  • Khamisi Mohamed
  • Evans Gichuru

Best Publications

  • Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort

    Elise Landais;Xiayu Huang;Colin Havenar-Daughton;Ben Murrell

  • Successes and challenges of HIV prevention in men who have sex with men

    Patrick S Sullivan;Alex Carballo-Diéguez;Thomas Coates;Steven M Goodreau

  • Men who have sex with men and HIV/AIDS in sub-Saharan Africa

    Adrian D Smith;Placide Tapsoba;Norbert Peshu;Eduard J Sanders;Eduard J Sanders

  • CXCL13 is a plasma biomarker of germinal center activity

    Colin Havenar-Daughton;Madelene Lindqvist;Antje Heit;Jennifer E. Wu

  • High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya

    Elisabeth Maria Van der Elst;Judie Mbogua;Don Operario;Gaudensia Mutua

  • Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort.

    Elise Landais;Xiayu Huang;Colin Havenar-Daughton;Colin Havenar-Daughton;Ben Murrell

  • HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya.

    Eduard J Sanders;Susan M Graham;Haile S Okuku;Elise M van der Elst

  • Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 [correction of 1966].

    E J Sanders;J G Rigau-Pérez;H L Smits;C C Deseda

  • CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa

    Etienne Karita;Nzeera Ketter;Matt A. Price;Kayitesi Kayitenkore

  • High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM.

    Eduard J. Sanders;Haile Selassie Okuku;Adrian D. Smith;Mary Mwangome

  • Defining HIV-1 transmission clusters based on sequence data.

    Amin S. Hassan;Oliver G. Pybus;Eduard J. Sanders;Jan Albert

  • Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.

    Gaudensia Mutua;Eduard J. Sanders;Eduard J. Sanders;Peter Mwangi Mugo;Omu Anzala

  • Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

    Matt A. Price;Carole L. Wallis;Shabir Lakhi;Etienne Karita

  • Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.

    Etienne Karita;Matt Price;Eric Hunter;Elwyn Chomba

  • Dynamics and constraints of early infant diagnosis of HIV infection in rural Kenya

    Amin S. Hassan;Erick M. Sakwa;Helen M. Nabwera;Miriam M. Taegtmeyer

  • First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations.

    E J Sanders;A A Marfin;P M Tukei;G Kuria

  • Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch

    Daniel T. MacLeod;Nancy M. Choi;Bryan Briney;Bryan Briney;Fernando Garces;Fernando Garces

  • Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.

    Matthew A. Price;Wasima Rida;Mary Mwangome;Gaudensia Mutua

  • Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

    Judd L Walson;Phelgona A Otieno;Margaret Mbuchi;Barbra A Richardson

  • Men who have sex with men sensitivity training reduces homoprejudice and increases knowledge among Kenyan healthcare providers in coastal Kenya.

    Elise M. van der Elst;Adrian D. Smith;Evanson Gichuru;Elizabeth Wahome

  • Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis.

    Simon Chengo Masha;Piet Cools;Eduard J Sanders;Mario Vaneechoutte

  • Clinical and public health implications of acute and early HIV detection and treatment: a scoping review

    Sarah E. Rutstein;Jintanat Ananworanich;Sarah Fidler;Cheryl Johnson

  • Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia

    Georges Reniers;Tekebash Araya;Gail Davey;Nico Nagelkerke

Frequent Co-Authors

Matthew Price
Matthew Price University of Vermont
Jill Gilmour
Jill Gilmour Imperial College London
Anatoli Kamali
Anatoli Kamali International AIDS Vaccine Initiative
Eric Hunter
Eric Hunter Emory University
Susan Allen
Susan Allen Emory University
Tobias F. Rinke de Wit
Tobias F. Rinke de Wit University of Amsterdam
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
Patricia E. Fast
Patricia E. Fast International AIDS Vaccine Initiative
James A. Berkley
James A. Berkley University of Oxford
Pontiano Kaleebu
Pontiano Kaleebu London School of Hygiene & Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career opportunities in healthcare and research. For those interested in clinical practice, transitioning into nursing can be a strategic move. Programs like the nurse practitioner accelerated program offer an efficient path for professionals aiming to advance quickly in patient care roles.

For individuals new to nursing, exploring online ADN programs for non nurses provides accessible entry points to start a nursing career without prior experience. These programs emphasize flexibility and foundational knowledge essential for healthcare settings.

Students seeking a streamlined route may also consider the easiest ABSN program to get into, which typically offers a fast-track Bachelor of Science in Nursing degree designed for those who already hold a degree in another field. This pathway can complement immunology expertise with practical nursing skills.

Additionally, becoming a Licensed Practical Nurse (LPN) is another viable healthcare pathway. The best easiest LPN programs to get into can provide quick access to foundational nursing roles, ideal for those who want to enter the workforce promptly while exploring further education options later.

Best Scientists Citing Eduard J. Sanders

Trending Scientists

Recently Published Articles